IN2012DN01863A - - Google Patents

Download PDF

Info

Publication number
IN2012DN01863A
IN2012DN01863A IN1863DEN2012A IN2012DN01863A IN 2012DN01863 A IN2012DN01863 A IN 2012DN01863A IN 1863DEN2012 A IN1863DEN2012 A IN 1863DEN2012A IN 2012DN01863 A IN2012DN01863 A IN 2012DN01863A
Authority
IN
India
Prior art keywords
taurine
lowering
composition
active ingredient
uric acid
Prior art date
Application number
Other languages
English (en)
Inventor
Fuminori Kimura
Hideaki Kitajima
Takao Tanaka
Toru Nishikawa
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Publication of IN2012DN01863A publication Critical patent/IN2012DN01863A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN1863DEN2012 2009-09-17 2010-09-10 IN2012DN01863A (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2009215092 2009-09-17
PCT/JP2010/065627 WO2011034006A1 (ja) 2009-09-17 2010-09-10 血液中の尿酸値を低下させるための組成物

Publications (1)

Publication Number Publication Date
IN2012DN01863A true IN2012DN01863A (sr) 2015-07-17

Family

ID=43758611

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1863DEN2012 IN2012DN01863A (sr) 2009-09-17 2010-09-10

Country Status (9)

Country Link
US (1) US9101588B2 (sr)
JP (1) JP6112767B2 (sr)
KR (1) KR20120068006A (sr)
CN (1) CN102655862A (sr)
IN (1) IN2012DN01863A (sr)
MX (1) MX2012003290A (sr)
SG (1) SG10201405790UA (sr)
TW (1) TW201116275A (sr)
WO (1) WO2011034006A1 (sr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2013018706A1 (ja) * 2011-08-03 2015-03-05 大正製薬株式会社 Urat1活性を調節するための組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006213607A (ja) * 2005-02-01 2006-08-17 Asahi Breweries Ltd 尿酸値低下剤

Also Published As

Publication number Publication date
CN102655862A (zh) 2012-09-05
KR20120068006A (ko) 2012-06-26
SG10201405790UA (en) 2014-11-27
JPWO2011034006A1 (ja) 2013-02-14
TW201116275A (en) 2011-05-16
US9101588B2 (en) 2015-08-11
US20120190886A1 (en) 2012-07-26
JP6112767B2 (ja) 2017-04-12
WO2011034006A1 (ja) 2011-03-24
MX2012003290A (es) 2012-04-30

Similar Documents

Publication Publication Date Title
MX2012001690A (es) Heterociclos microbicidas.
MY183312A (en) Pharmaceutical formulation
TN2012000152A1 (en) Spiropiperidine compounds and pharmaceutical use thereof for treating diabetes
MX2011011733A (es) Inhiibidores de dihidroorotato deshidrogenasa como compuestos virostaticos.
MY158982A (en) Heterocyclic compound
WO2009041705A3 (en) 5-membered heterocyclic compounds as proton pump inhibitors
EA201190227A1 (ru) Оксазолзамещенные индазолы в качестве ингибиторов pi3-киназ
PH12012501052A1 (en) Novel spiropiperidine compounds
ZA201106326B (en) Multi-part kit system for the preparation of a disinfectant of the peracetic acid type
EP2432774A4 (en) COMPOUNDS, COMPOSITIONS AND METHODS FOR MODULATING URIC ACID RATES
TN2012000578A1 (en) Tetrahydro-pyrido-pyrimidine derivatives
PH12012500630A1 (en) Spiro-condensed cyclohexane derivatives as hsl inhibitors useful for the treatment of diabetes
MY169734A (en) Methods for improving pharmacokinetics
PT2462098E (pt) Processos para a preparação de derivados de ácido 1-(2- halobifenil-4-il)-ciclopropanocarboxílico
MX2010009926A (es) Nuevo proceso para la preparacion de derivados de acido ciclohexancarboxilico.
MX2012004087A (es) Sulfonamidas para la prevencion de diabetes.
MX2014005399A (es) Metodos para tratar gota en sub-poblaciones de pacientes.
MX2012003290A (es) Composicion para reducir el nivel de acido urico en la sangre.
TR201009166A2 (tr) Sefdinir içeren farmasötik bileşim için üretim yöntemi
MX2013002656A (es) Nuevo proceso.
WO2011161295A3 (es) Uso de compuestos anticalcineurina para el tratamiento de patologías que cursan con neovascularización ocular
UA38601U (en) 2,2'-dithioxo-4,4'-dioxo-[5,5']-bithiazolidinyl-idene-diyl-3,3'-dibutanoic acid diarylamides having antitumor activity
UA44361U (ru) Соединение 2-(n-параметилфенилсукцинимидо-3)-меркаптобензойная кислота, которая имеет потенциальную физиологическую активность
UA44364U (ru) Соединение 2-(n-ортохлорфенилсукцинимидо-3)-меркаптобензойная кислота, которая имеет потенциальную физиологическую активность
UA94136C2 (ru) Н-бутиламид 4-метил-7-хлор-2-оксо-1,2-дигмдрохинолин-6-сульфоновой кислоты, проявляющий диуретическую активность